These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 9607536
1. Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Liu CL, Ngan H, Lo CM, Fan ST. Br J Surg; 1998 Apr; 85(4):512-4. PubMed ID: 9607536 [Abstract] [Full Text] [Related]
2. Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Battula N, Srinivasan P, Madanur M, Chava SP, Priest O, Rela M, Heaton N. Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):49-51. PubMed ID: 17287166 [Abstract] [Full Text] [Related]
3. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases]. Levy I, Verstandig A, Sasson T, Wolf D, Krichon I, Libson E, Levensart P, Papo O, Yurim O, Id A, Shouval D. Harefuah; 2000 Jan 16; 138(2):89-93, 174. PubMed ID: 10883065 [Abstract] [Full Text] [Related]
4. Caffeine clearance in patients with hepatocellular carcinoma after transcatheter oily chemoembolization treatment. Thong-Ngam D, Thumvijit L, Tangkijvanich P, Janchai A, Mahachai V, Wittayalertpanya S. J Med Assoc Thai; 2002 Dec 16; 85(12):1280-7. PubMed ID: 12678165 [Abstract] [Full Text] [Related]
5. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization. Kimura S, Okazaki M, Higashihara H, Haruno M, Nozaki Y, Urakawa H, Kora S, Shinagawa Y, Nonokuma M. Hepatogastroenterology; 2009 Dec 16; 56(89):191-8. PubMed ID: 19453056 [Abstract] [Full Text] [Related]
6. Management of hepatocellular carcinoma in renal transplant recipients. Chok KS, Lam CM, Li FK, Ng KK, Poon RT, Lo CM, Fan ST. J Surg Oncol; 2004 Sep 01; 87(3):139-42. PubMed ID: 15334642 [Abstract] [Full Text] [Related]
7. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Kim IS, Lim YS, Lee HC, Suh DJ, Lee YJ, Lee SG. Aliment Pharmacol Ther; 2008 Feb 15; 27(4):338-45. PubMed ID: 18047564 [Abstract] [Full Text] [Related]
8. Spontaneous rupture of hepatocellular carcinoma: a Western experience. Battula N, Madanur M, Priest O, Srinivasan P, O'Grady J, Heneghan MA, Bowles M, Muiesan P, Heaton N, Rela M. Am J Surg; 2009 Feb 15; 197(2):164-7. PubMed ID: 18926518 [Abstract] [Full Text] [Related]
9. [Transarterial oily chemoembolization combined with interstitial laser thermotherapy for treatment of hepatocellular carcinoma]. Zhou ZJ, Xu RD, Li WK, Zhuang WX, Lu LG, Shao PJ, Chen XM, Luo PF. Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec 15; 27(12):1866-8. PubMed ID: 18159005 [Abstract] [Full Text] [Related]
10. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. O'Suilleabhain CB, Poon RT, Yong JL, Ooi GC, Tso WK, Fan ST. Br J Surg; 2003 Mar 15; 90(3):325-31. PubMed ID: 12594668 [Abstract] [Full Text] [Related]
11. Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. Liu CL, Fan ST, Lo CM, Tso WK, Poon RT, Lam CM, Wong J. J Clin Oncol; 2001 Sep 01; 19(17):3725-32. PubMed ID: 11533094 [Abstract] [Full Text] [Related]
12. Transcatheter oily chemoembolization of the extrahepatic collaterals in hepatocellular carcinoma. Eurvilaichit C. J Med Assoc Thai; 2000 Nov 01; 83(11):1393-401. PubMed ID: 11215872 [Abstract] [Full Text] [Related]
13. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer. Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK. J Nucl Med; 2009 Jun 01; 50(6):871-7. PubMed ID: 19443599 [Abstract] [Full Text] [Related]
14. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L. Am J Clin Oncol; 2003 Aug 01; 26(4):e92-9. PubMed ID: 12902905 [Abstract] [Full Text] [Related]
15. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Malagari K, Alexopoulou E, Chatzimichail K, Hall B, Koskinas J, Ryan S, Gallardo E, Kelekis A, Gouliamos A, Kelekis D. Abdom Imaging; 2008 Aug 01; 33(5):512-9. PubMed ID: 17938995 [Abstract] [Full Text] [Related]
16. Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma. Yeh CN, Lee WC, Jeng LB, Chen MF, Yu MC. Br J Surg; 2002 Sep 01; 89(9):1125-9. PubMed ID: 12190677 [Abstract] [Full Text] [Related]
17. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma. Kawaoka T, Aikata H, Takaki S, Katamura Y, Hiramatsu A, Waki K, Takahashi S, Hieda M, Toyota N, Ito K, Chayama K. Cardiovasc Intervent Radiol; 2009 Jul 01; 32(4):687-94. PubMed ID: 19444503 [Abstract] [Full Text] [Related]
18. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. J Gastroenterol Hepatol; 2009 May 01; 24(5):806-14. PubMed ID: 19207681 [Abstract] [Full Text] [Related]
19. [Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma]. Kim YI, Ki HS, Kim MH, Cho DK, Cho SB, Joo YE, Kim HS, Choi SK, Rew JS. Korean J Hepatol; 2009 Jun 01; 15(2):148-58. PubMed ID: 19581767 [Abstract] [Full Text] [Related]
20. Cytolysis following chemoembolization for hepatocellular carcinoma. Paye F, Farges O, Dahmane M, Vilgrain V, Flejou JF, Belghiti J. Br J Surg; 1999 Feb 01; 86(2):176-80. PubMed ID: 10100782 [Abstract] [Full Text] [Related] Page: [Next] [New Search]